Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Annals of allergy, asthma immunology[TA])
5,161 results
  • Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis. [Journal Article]
  • AAAnn Allergy Asthma Immunol 2016 Dec 03
  • Whittington MD, McQueen RB, … Campbell JD
  • CONCLUSIONS: The estimated cost effectiveness of mepolizumab exceeds value thresholds. Achieving these thresholds would require significant discounts from the current list price. Alternatively, treatment limited to responders improves the cost effectiveness toward, but remains still slightly above, these thresholds. Payers interested in improving the efficiency of health care resources should consider negotiations of the mepolizumab price and ways to predict and assess the response to mepolizumab.
New Search Next